1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Bradley Connor: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of AEMCOLO (Rifamycin SV MMX) in the Treatment of Small Intestinal Bacterial Overgrowth (SIBO) AEMCOLO (Rifamycin SV MMX) - Small Intestinal Bacterial Overgrowth, Gastrointestinal Disease | Phase 2 | Unknown | Bradley Connor | 30 | 2020-06-30 | 2022-05-05 |
rifamycin SV (1)
United States (1)